SPX4,274.04-31.16 -0.72%
DIA340.20-1.54 -0.45%
IXIC12,938.12-164.43 -1.25%

BRIEF-Tonix Pharma Collaborates With Kenya Medical Research Institute To Develop TNX-801 In Kenya

BRIEF-Tonix Pharma Collaborates With Kenya Medical Research Institute To Develop TNX-801 In Kenya

Reuters · 07/28/2022 07:41
BRIEF-Tonix Pharma Collaborates With Kenya Medical Research Institute To Develop TNX-801 In Kenya

- Tonix Pharmaceuticals Holding Corp TNXP:

  • TONIX PHARMACEUTICALS ANNOUNCES COLLABORATION WITH KENYA MEDICAL RESEARCH INSTITUTE TO DEVELOP TNX-801 IN KENYA AS A VACCINE FOR THE PREVENTION OF MONKEYPOX AND SMALLPOX INFECTION

  • TONIX PHARMACEUTICALS HOLDING CORP - PHASE 1 CLINICAL STUDY EXPECTED TO BE INITIATED IN KENYA IN FIRST HALF OF 2023

Source text for Eikon: ID:

Further company coverage: TNXP


((Reuters.Briefs@thomsonreuters.com;))